-
Founded in:
2006-01-26 -
Country:
China -
Address:
No. 279, Lvgu Avenue, Shuige Industrial Zone, Zhejiang Province -
Tax NO.:
91331100773112151W -
Registered Funds:
40.5 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Molecular iodine |
The rapid release of iodine molecules under the action of saliva can directly oxidize and halogenate bacterial proteins, and has a killing effect on a variety of bacterial reproductive bodies, fungi, spores, viruses, etc.
More
The rapid release of iodine molecules under the action of saliva can directly oxidize and halogenate bacterial proteins, and has a killing effect on a variety of bacterial reproductive bodies, fungi, spores, viruses, etc. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Potassium L-aspartate |
Aspartic acid has a strong affinity for cells and can be used as a carrier to facilitate the entry of potassium ions and magnesium ions into the cytoplasm and mitochondria to maintain the normal excitability and stability of the internal environment of nerve tissue, myocardium, smooth muscle and other cells. It can transport electrolytes to the myocardium, promote myocyte depolarization, maintain myocardial contractility, and reduce myocardial oxygen consumption. It has a protective effect on the myocardium when hypoxia is caused by coronary circulation disorders.
More
Aspartic acid has a strong affinity for cells and can be used as a carrier to facilitate the entry of potassium ions and magnesium ions into the cytoplasm and mitochondria to maintain the normal excitability and stability of the internal environment of nerve tissue, myocardium, smooth muscle and other cells. It can transport electrolytes to the myocardium, promote myocyte depolarization, maintain myocardial contractility, and reduce myocardial oxygen consumption. It has a protective effect on the myocardium when hypoxia is caused by coronary circulation disorders. |
158mg | 14007-45-5 | 11 |
| Magnesium L-aspartate |
Aspartic acid participates in the ornithine cycle, promotes urea production, reduces ammonia and carbon dioxide levels in the blood, and enhances liver function.
More
Aspartic acid participates in the ornithine cycle, promotes urea production, reduces ammonia and carbon dioxide levels in the blood, and enhances liver function. |
140mg | 2068-80-6 | 7 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Erythromycin |
This product belongs to the macrolide antibiotics. It inhibits bacterial protein synthesis by binding to the 50S subunit of the ribosome of sensitive bacteria. It has antibacterial activity against Staphylococcus (except methicillin-resistant strains), all groups of streptococci and Gram-positive bacilli. Streptococcus pyogenes, group A hemolytic streptococci, Staphylococcus, Streptococcus pneumoniae, meningococci, gonorrhea, Bordetella pertussis, etc. are also sensitive to this product. This product also has antibacterial effects on various anaerobic bacteria except Bacteroides fragilis and Fusobacterium. It also has inhibitory effects on Mycoplasma pneumoniae, Chlamydia, Legionella, Treponema pallidum, Leptospira, and Campylobacter fetus. Non-clinical toxicology studies: In long-term (2-year) studies on rats, there is no evidence of carcinogenicity or gene mutation after oral administration of erythromycin; studies on male and female rats.
More
This product belongs to the macrolide antibiotics. It inhibits bacterial protein synthesis by binding to the 50S subunit of the ribosome of sensitive bacteria. It has antibacterial activity against Staphylococcus (except methicillin-resistant strains), all groups of streptococci and Gram-positive bacilli. Streptococcus pyogenes, group A hemolytic streptococci, Staphylococcus, Streptococcus pneumoniae, meningococci, gonorrhea, Bordetella pertussis, etc. are also sensitive to this product. This product also has antibacterial effects on various anaerobic bacteria except Bacteroides fragilis and Fusobacterium. It also has inhibitory effects on Mycoplasma pneumoniae, Chlamydia, Legionella, Treponema pallidum, Leptospira, and Campylobacter fetus. Non-clinical toxicology studies: In long-term (2-year) studies on rats, there is no evidence of carcinogenicity or gene mutation after oral administration of erythromycin; studies on male and female rats. |
114-07-8 | 43 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Erythromycin |
This product belongs to the macrolide antibiotics. It inhibits bacterial protein synthesis by binding to the 50S subunit of the ribosome of sensitive bacteria. It has antibacterial activity against Staphylococcus (except methicillin-resistant strains), all groups of streptococci and Gram-positive bacilli. Streptococcus pyogenes, group A hemolytic streptococci, Staphylococcus, Streptococcus pneumoniae, meningococci, gonorrhea, Bordetella pertussis, etc. are also sensitive to this product. This product also has antibacterial effects on various anaerobic bacteria except Bacteroides fragilis and Fusobacterium. It also has inhibitory effects on Mycoplasma pneumoniae, Chlamydia, Legionella, Treponema pallidum, Leptospira, and Campylobacter fetus.
More
This product belongs to the macrolide antibiotics. It inhibits bacterial protein synthesis by binding to the 50S subunit of the ribosome of sensitive bacteria. It has antibacterial activity against Staphylococcus (except methicillin-resistant strains), all groups of streptococci and Gram-positive bacilli. Streptococcus pyogenes, group A hemolytic streptococci, Staphylococcus, Streptococcus pneumoniae, meningococci, gonorrhea, Bordetella pertussis, etc. are also sensitive to this product. This product also has antibacterial effects on various anaerobic bacteria except Bacteroides fragilis and Fusobacterium. It also has inhibitory effects on Mycoplasma pneumoniae, Chlamydia, Legionella, Treponema pallidum, Leptospira, and Campylobacter fetus. |
114-07-8 | 43 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Fenoprofen calcium |
It reduces the synthesis of prostaglandins by inhibiting cyclooxygenase, thereby alleviating tissue congestion and swelling and reducing the sensitivity of peripheral nerve pain. It has an antipyretic effect through the hypothalamic temperature regulation center.
More
It reduces the synthesis of prostaglandins by inhibiting cyclooxygenase, thereby alleviating tissue congestion and swelling and reducing the sensitivity of peripheral nerve pain. It has an antipyretic effect through the hypothalamic temperature regulation center. |
53746-45-5 | 10 |